Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Starling Oncology, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −2 vs. Q2 2023
- Shares held
- 15.1M
- +1.19M (+8.6%) vs. Q2 2023
- Total value
- $21.2M
- +$13.5M (+176.5%) vs. Q2 2023
- New holders
- 9
- 11 more added
- Sold out
- 11
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $217.6M |
| Q1 2026 | 115 | $118.9M |
| Q4 2025 | 117 | $137.1M |
| Q3 2025 | 108 | $121.0M |
| Q2 2025 | 79 | $65.5M |
| Q1 2025 | 43 | $19.4M |
| Q4 2024 | 31 | $4.61M |
| Q3 2024 | 34 | $6.73M |
| Q2 2024 | 39 | $8.60M |
| Q1 2024 | 47 | $27.2M |
| Q4 2023 | 45 | $37.6M |
| Q3 2023 | 36 | $21.2M |
| Q2 2023 | 38 | $7.66M |
| Q1 2023 | 39 | $14.9M |
| Q4 2022 | 40 | $38.7M |
| Q3 2022 | 39 | $108.4M |
| Q2 2022 | 36 | $110.9M |
| Q1 2022 | 29 | $159.0M |
| Q4 2021 | 21 | $199.9M |
| Q3 2021 | 1 | $2.50M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 100 | $140 | 0.00% | +58+138.1% | Added |
| Wells Fargo & Company | 229 | $321 | 0.00% | +44+23.8% | Added |
| Toronto Dominion Bank | 336 | $470 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 498 | $697 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,175 | $3.04K | 0.00% | −10,037−82.2% | Reduced |
| Bank of America Corp | 3,906 | $5.47K | 0.00% | −2−0.1% | Reduced |
| Morgan Stanley | 5,462 | $7.65K | 0.00% | −4,038−42.5% | Reduced |
| Royal Bank of Canada | 7,870 | $11.0K | 0.00% | +108+1.4% | Added |
| Deutsche Bank AG | 9,435 | $13.2K | 0.00% | −10,936−53.7% | Reduced |
| Prudential Financial Inc | 13,000 | $18.2K | 0.00% | +13,000 | New |
| Virtu Financial LLC | 14,044 | $20.0K | 0.00% | +14,044 | New |
| First Republic Investment Management, Inc. | 18,300 | $25.6K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 18,302 | $25.6K | 0.00% | +1,391+8.2% | Added |
| Brown Advisory Inc | 18,674 | $26.1K | 0.00% | 00.0% | Unchanged |
| JustInvest LLC | 21,269 | $29.8K | 0.00% | +21,269 | New |
| Qube Research & Technologies Ltd | 21,301 | $29.8K | 0.00% | −49,217−69.8% | Reduced |
| Pinebridge Investments, L.P. | 29,779 | $41.7K | 0.00% | +29,779 | New |
| Citadel Advisors LLC | 42,717 | $59.8K | 0.00% | +42,717 | New |
| Northern Trust Corp | 44,588 | $62.4K | 0.00% | −3,522−7.3% | Reduced |
| XTX Topco Ltd | 46,100 | $64.5K | 0.01% | +46,100 | New |
| Prelude Capital Management, LLC | 49,869 | $69.8K | 0.01% | +8,652+21.0% | Added |
| Renaissance Technologies LLC | 72,300 | $101.0K | 0.00% | −3,342−4.4% | Reduced |
| State Street Corp | 78,000 | $109.2K | 0.00% | +6,000+8.3% | Added |
| Saba Capital Management, L.P. | 94,264 | $132.0K | 0.00% | −76,114−44.7% | Reduced |
| Millennium Management LLC | 97,322 | $136.3K | 0.00% | −105,356−52.0% | Reduced |
| Diametric Capital, LP | 155,344 | $217.5K | 0.09% | +26,952+21.0% | Added |
| Kent Lake Capital LLC | 183,215 | $256.5K | 0.10% | +183,215 | New |
| BlackRock Inc. | 237,846 | $333.0K | 0.00% | +88,415+59.2% | Added |
| Geode Capital Management, LLC | 305,501 | $427.8K | 0.00% | +45,082+17.3% | Added |
| Tiff Advisory Services Inc | 423,405 | $592.8K | 0.50% | +423,405 | New |
| Balyasny Asset Management LLC | 437,579 | $612.6K | 0.00% | +437,579 | New |
| Hongkou Capital LP | 904,689 | $1.27M | 5.36% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,758,034 | $2.46M | 0.00% | −4,916−0.3% | Reduced |
| Josh Arnold Investment Consultant, LLC | 1,877,472 | $2.65M | 2.76% | +819,321+77.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 3,360,052 | $4.70M | 0.10% | 00.0% | Unchanged |
| FMR LLC | 4,754,183 | $6.66M | 0.00% | +1000.0% | Added |
| Prosight Management, LP | 0 | $0 | 0.00% | −455,302−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −138,899−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −52,740−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −35,621−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −22,974−100.0% | Sold out |
| Nwam LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −14,147−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,640−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −3,226−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,414−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −309−100.0% | Sold out |